Evidence map›Paper›PMID 32533435›Full record

ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020

Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives.

M Aapro, P Bossi, A Dasari, L Fallowfield, P Gascón, M Geller, K Jordan, J Kim, K Martin, S Porzig

2 registry-linked trialsOpen access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 173 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 14 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05064787 nacompletednot on this mapstarted 2022, after this paper: background citation

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

TypeinterventionalSponsorPack HealthRan2022 to 2024Enrolled45ConditionsLymphoma, Lymphoma, B-Cell, Leukemia, Multiple MyelomaArmsDigital Health Coaching
NCT05349227 narecruitingnot on this mapstarted 2022, after this paper: background citation

Comprehensive Outcomes for After Cancer Health (COACH): the Feasibility and Impact of an MHealth Augmented Coaching Program for Self-Management in Cancer Survivors

TypeinterventionalSponsorPack HealthRan2022 to 2027Enrolled625ConditionsOvarian Cancer, Breast Cancer, Lung Cancer, Gastric CancerArmsDigital Health Coaching Program, Fitbit
3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 14 syntheses or guidelines pooled it, 314 citations in OpenAlex.

  1. Feasibility and preliminary effects of mhealth supportive care interventions in adults with myeloid neoplasms: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Barriers and facilitators for implementing patient-reported outcome measures in oncology practices: an umbrella review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Trial
  16. Effectiveness of mobile-based monitoring system (ONKOSIS) in the management of chemotherapy-related symptoms: a randomized controlled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial
  17. Trial
  18. Trial
  19. Trial
  20. Factors associated with distress over time in women with breast cancer undergoing radiotherapy: insights from a pilot study assessing a digital information tool.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Trial

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 10 institutions in 6 countries.

M AaproMedical Oncology, Genolier Cancer Center, Clinique de Genolier, Genolier, Switzerland. maapro@genolier.net.
P BossiDepartment of Medical Oncology, University of Brescia, Brescia, Italy.
A DasariDepartment of Gastrointestinal Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA.
L FallowfieldSussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Brighton, UK.
P GascónDepartment of Hematology-Oncology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
M GellerGynecologic Oncology, Department of Obstetrics, Gynecology and Women's Health (OBGYN), University of Minnesota, Minneapolis, MN, USA.
K JordanDepartment of Medicine, Haematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
J KimMedical Oncology, Yale University School of Medicine, New Haven, CT, USA.
K MartinGyneco-oncology, Barnes-Jewish Hospital, St. Louis, MO, USA.
S PorzigMedical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Barnes-Jewish Hospital · USClinique de Genolier · CHFox Chase Cancer Center · USHospital Clínic de Barcelona · ESThe University of Texas MD Anderson Cancer Center · USUniversity Hospital Heidelberg · DEUniversity of Brescia · ITUniversity of Minnesota · USUniversity of Sussex · GBYale University · US

Funding

Voluntis NA
6 · The paper itself

Abstract

backgroundDigital health provides solutions that capture patient-reported outcomes (PROs) and allows symptom monitoring and patient management. Digital therapeutics is the provision to patients of evidence-based therapeutic interventions through software applications aimed at prevention, monitoring, management, and treatment of symptoms and diseases or for treatment optimization. The digital health solutions collecting PROs address many unmet needs, including access to care and reassurance, increase in adherence and treatment efficacy, and decrease in hospitalizations. With current developments in oncology including increased availability of oral drugs and reduced availability of healthcare professionals, these solutions offer an innovative approach to optimize healthcare resource utilization.

designThis scoping review clarifies the role and impact of the digital health solutions in oncology supportive care, with a view of the current segmentation according to their technical features (connection to sensors, PRO collection, remote monitoring, self-management in real time…), and identifies evidence from clinical studies published about their benefits and limitations and drivers and barriers to adoption. A qualitative summary is presented.

resultsSixty-six studies were identified and included in the qualitative synthesis. Studies supported the use of 38 digital health solutions collecting ePROs and allowing remote monitoring, with benefits to patients regarding symptom reporting and management, reduction in symptom distress, decrease in unplanned hospitalizations and related costs and improved quality of life and survival. Among those 38 solutions 21 provided patient self-management with impactful symptom support, improvement of QoL, usefulness and reassurance. Principal challenges are in developing and implementing digital solutions to suit most patients, while ensuring patient compliance and adaptability for use in different healthcare systems and living environments.

conclusionsThere is growing evidence that digital health collecting ePROs provide benefits to patients related to clinical and health economic endpoints. These digital solutions can be integrated into routine supportive care in oncology practice to provide improved patient-centered care.

Indexed as

HumansMedical OncologyQuality of LifeTelemedicineDigital therapeuticseHealthIntegrative oncologyPatient-reported outcomesSelf-managementSymptom monitoring

Identifiers

PMID32533435
PMCPMC7447627
OpenAlexW3034364899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.